Folic Acid

Folic Acid, Folate, Vitamin B9, Pteroyl L-glutamic acid

Vitamin B9 is an ##essential## water-soluble ##vitamin## better known as folic acid, that can be found as a synthetic supplement. It is important for various functions of the body, such as DNA synthesis and repair, cell division and growth, ##protein## production, and red cell formation. It is also essential for cardiovascular and nervous system health. Folic acid supplements are commonly consumed during pregnancy to prevent fetal neural tube defects, which may occur with B9 deficiency.

Nutraceutic

  • Origin Plant Based, Synthetic
  • Source Leafy Greens, Synthetic, grains, avocado, nuts
  • Type Vitamin
  • Age Range Children (0-12), Teenagers (13-19), Adults (20-59), Seniors (>60)
  • Toxicity May be toxic in high doses
  • Side effects Abdominal Pain, Diarrhea, Irritability, Nausea, Allergy, Drowsiness
  • Warnings Vitamin B12 Defficiency

Why be Careful

In high doses, folic acid supplementation may cause undesirable adverse health effects. Individuals with vitamin B12 deficiency should not consume folic acid, as its consumption may mask anemia caused by vitamin B12 deficiency and therefore delay appropriate treatment.

References

  1. a b Kawashima A, et al. Four week supplementation with mixed fruit and vegetable juice concentrates increased protective serum antioxidants and folate and decreased plasma homocysteine in Japanese subjectsAsia Pac J Clin Nutr. (2007)
  2. a b Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementationN Engl J Med. (1992)
  3. ^ Almeida OP, et al. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trialAnn Neurol. (2010)
  4. ^ Ford AH, et al. Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trialJ Clin Psychiatry. (2008)
  5. a b c Christensen H, et al. No clear potentiation of antidepressant medication effects by folic acid+vitamin B12 in a large community sampleJ Affect Disord. (2011)
  6. a b Ji HF, Tang GY, Zhang HY. A theoretical study on the structure-activity relationships of metabolites of folates as antioxidants and its implications for rational design of antioxidantsBioorg Med Chem. (2005)
  7. ^ Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depressionAltern Med Rev. (2008)
  8. ^ Florio R, et al. Serine hydroxymethyltransferase: a model enzyme for mechanistic, structural, and evolutionary studiesBiochim Biophys Acta. (2011)
  9. ^ Bhargava S, Tyagi SC. Nutriepigenetic regulation by folate-homocysteine-methionine axis: a reviewMol Cell Biochem. (2014)
  10. ^ Mato JM, et al. S-adenosylmethionine synthesis: molecular mechanisms and clinical implicationsPharmacol THer. (1997)
  11. ^ Turner MA, et al. Structure and function of S-adenosylhomocysteine hydrolaseCell Biochem Biophys. (2000)
  12. a b c d e Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and CholineInstitute of Medicine. (1998)
  13. ^ Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, and future directionsNutrients. (2011)
  14. ^ Craig GM, Elliot C, Hughes KR. Masked vitamin B12 and folate deficiency in the elderlyBr J Nutr. (1985)
  15. ^ Ellison AB. Pernicious anemia masked by multivitamins containing folic acidJ Am Med Assoc. (1960)
  16. ^ Allen RH, et al. Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrationsAm J Hematol. (1990)
  17. ^ Crosby WH. The danger of folic acid in multivitamin preparationsMil Med. (1960)
  18. a b Agamanolis DP, et al. Neuropathology of experimental vitamin B12 deficiency in monkeysNeurology. (1976)
  19. a b c Morris MS, et al. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortificationAm J Clin Nutr. (2007)
  20. a b Hunter R, et al. Toxicity of folic acid given in pharmacological doses to healthy volunteersLancet. (1970)
  21. a b Gibberd FB, et al. Toxicity of folic acidLancet. (1970)
  22. a b Hellström L. Lack of toxicity of folic acid given in pharmacological doses to healthy volunteersLancet. (1971)
  23. a b Richens A. Toxicity of folic acidLancet. (1971)
  24. a b Sheehy TW. Folic acid: lack of toxicityLancet. (1973)
  25. a b Suarez RM, Spies TD, Suarez RM Jr.. The use of folic acid in sprueAnn Intern Med. (1947)
  26. a b c d e f Kelly P, et al. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplementsAm J Clin Nutr. (1997)
  27. a b c d Sweeney MR, McPartlin J, Scott J. Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serumBMC Public Health. (2007)
  28. a b c d e Troen AM et al.. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal womenJ Nutr. (2006)
  29. ^ Morris MS, et al. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniorsAm J Clin Nutr. (2010)
  30. a b c d Christensen KE et al.. High folic acid consumption leads to pseudo-MTHFR deficiency, altered lipid metabolism, and liver injury in miceAm J Clin Nutr. (2015)
  31. ^ Lok A et al.. The one-carbon-cycle and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in recurrent major depressive disorder; influence of antidepressant use and depressive state?J Affect Disord. (2014)
  32. a b c d Wright AJ, Dainty JR, Finglas PM. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UKBr J Nutr. (2007)
  33. ^ Obeid R. The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathwayNutrients. (2013)
  34. ^ Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseasesEur J Med Genet. (2015)
  35. a b Yan J et al.. MTHFR C677T genotype influences the isotopic enrichment of one-carbon metabolites in folate-compromised men consuming d9-cholineAm J Clin Nutr. (2011)
  36. a b c d e f Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE reviewAm J Epidemiol. (2007)
  37. ^ Rozen R. Molecular genetics of methylenetetrahydrofolate reductase deficiencyJ Inherit Metab Dis. (1996)
  38. ^ Lievers KJ et al.. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease riskJ Mol Med (Berl). (2001)
  39. ^ Goyette P, et al. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiencyAm J Hum Genet. (1995)
  40. ^ Goyette P, et al. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFRAm J Hum Genet. (1996)
  41. ^ Trembath D et al.. Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect populationTeratology. (1999)
  42. a b Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE reviewAm J Epidemiol. (2000)
  43. ^ Vandana Rai, et al. Maternal Methylenetetrahydrofolate Reductase C677T Polymorphism and Down Syndrome Risk: A Meta-Analysis from 34 StudiesPLoS One. (2014)
  44. a b c Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE reviewAm J Epidemiol. (2004)
  45. ^ Bjelland I, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine StudyArch Gen Psychiatry. (2003)
  46. ^ Lewis SJ, Ebrahim S, Davey Smith G. Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?BMJ. (2005)
  47. ^ David S Wald, Malcolm Law, and Joan K Morris. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ. (2002)
  48. ^ Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Leukemia Risk: A HuGE MinireviewAm J Epidemiol. (2003)
  49. ^ Chandler CJ, Wang TT, Halsted CH. Pteroylpolyglutamate hydrolase from human jejunal brush borders. Purification and characterizationJ Biol Chem. (1986)
  50. a b Strum WB. Enzymatic reduction and methylation of folate following pH-dependent, carrier-mediated transport in rat jejunumBiochim Biophys Acta. (1979)
  51. ^ Bhandari SD, Gregory JF 3rd. Folic acid, 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate exhibit equivalent intestinal absorption, metabolism and in vivo kinetics in ratsJ Nutr. (1992)
  52. ^ Clifford AJ, et al. The dynamics of folic acid metabolism in an adult given a small tracer dose of 14C-folic acidAdv Exp Med Biol. (1998)
  53. ^ Krumdieck CL, et al. A long-term study of the excretion of folate and pterins in a human subject after ingestion of 14C folic acid, with observations on the effect of diphenylhydantoin administrationAm J Clin Nutr. (1978)
  54. ^ Rogers LM, et al. A dual-label stable-isotopic protocol is suitable for determination of folate bioavailability in humans: evaluation of urinary excretion and plasma folate kinetics of intravenous and oral doses of {13C5} and {2H2}folic acidJ Nutr. (1997)
  55. a b Steinberg SE, Campbell CL, Hillman RS. Kinetics of the normal folate enterohepatic cycleJ Clin Invest. (1979)
  56. ^ Steinberg SE. Mechanisms of folate homeostasisAm J Physiol. (1984)
  57. ^ V. Michael Whitehead, et al. Intestinal Conversion of Folinic Acid to 5-Methyltetrahydrofolate in ManBr J Haematol. (1972)
  58. ^ Smith ME, Matty AJ, Blair JA. The transport of pteroylglutamic acid across the small intestine of the ratBiochim Biophys Acta. (1970)
  59. ^ Tani M, Iwai K. High-performance liquid chromatographic separation of physiological folate monoglutamate compounds. Investigation of absorption and conversion of pteroylglutamic acid in the small intestine of the rat in situJ CHromatogr. (1983)
  60. ^ Masters JN, Attardi G. The nucleotide sequence of the cDNA coding for the human dihydrofolic acid reductaseGene. (1983)
  61. ^ Obeid R, et al. Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adultsMetabolism. (2011)
  62. ^ Matherly LH, Hou Z, Deng Y. Human reduced folate carrier: translation of basic biology to cancer etiology and therapyCancer Metastasis Rev. (2007)
  63. ^ Leamon CP, Jackman AL. Exploitation of the folate receptor in the management of cancer and inflammatory diseaseVitam Horm. (2008)
  64. a b c d e Zhao R, et al. Mechanisms of membrane transport of folates into cells and across epitheliaAnnu Rev Nutr. (2011)
  65. ^ Zhao R, et al. Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cellsJ Biol Chem. (2001)
  66. ^ Zhao R, Matherly LH, Goldman ID. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissuesExpert Rev Mol Med. (2009)
  67. ^ Whetstine JR, Flatley RM, Matherly LH. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoterBiochem J. (2002)
  68. ^ Goldman ID, et al. The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogsCurr Opin Investig Drugs. (2010)
  69. ^ Said et al.. Adaptive regulation of intestinal folate uptake: effect of dietary folate deficiencyAm J Physiol Cell Physiol. (2000)
  70. a b Liu M et al.. Structure and regulation of the murine reduced folate carrier gene: identification of four noncoding exons and promoters and regulation by dietary folatesJ Biol Chem. (2005)
  71. a b Kamen BA, Smith AK. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitroAdv Drug Deliv Rev. (2004)
  72. ^ Ross JF, et al. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemiaCancer. (1999)
  73. ^ Wang H, et al. Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemiaBlood. (2000)
  74. a b c Yamaguchi T et al.. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptorImmunity. (20007)
  75. ^ Shen F, et al. Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificityBiochemistry. (1995)
  76. ^ Piedrahita JA et al.. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic developmentNat Genet. (1999)
  77. ^ Qiu A et al.. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorptionCell. (2006)
  78. a b Wang Y, Zhao R, Goldman ID. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrierClin Cancer Res. (2004)
  79. a b Zhao R, et al. Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathwayCancer Res. (2004)
  80. ^ Shayeghi M et al.. Identification of an intestinal heme transporterCell. (2005)
  81. ^ Qiu A et al.. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorptionCell. (2006)
  82. a b Ormazabal A et al.. Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: reference values for a paediatric populationClin Chim Acta. (2006)
  83. ^ Reynolds EH, Mattson RH, Gallagher BB. Relationships between serum and cerebrospinal fluid anticonvulsant drug and folic acid concentrations in epileptic patientsNeurology. (1972)
  84. a b Wesson VA, Levitt AJ, Joffe RT. Change in folate status with antidepressant treatmentPsychiatry Res. (1994)
  85. a b Fava M, et al. Folate, vitamin B12, and homocysteine in major depressive disorderAm J Psychiatry. (1997)
  86. a b c Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneityJ Epidemiol Community Health. (2007)
  87. a b c Ginsberg LD, Oubre AY, Daoud YA. L-methylfolate Plus SSRI or SNRI from Treatment Initiation Compared to SSRI or SNRI Monotherapy in a Major Depressive EpisodeInnov Clin Neurosci. (2011)
  88. a b c d e f g Wollack JB et al.. Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture modelJ Neurochem. (2008)
  89. ^ Serot JM, et al. CSF-folate levels are decreased in late-onset AD patientsJ Neural Transm (Vienna). (2001)
  90. ^ Moretti P et al.. Cerebral folate deficiency with developmental delay, autism, and response to folinic acidNeurology. (2005)
  91. ^ Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE reviewAm J Epidemiol. (2007)
  92. ^ Wu D, Pardridge WM. Blood-brain barrier transport of reduced folic acidPharm Res. (1999)
  93. ^ Zhao et al.. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorptionBlood. (2007)
  94. a b Baxter MG, Miller AA, Webster RA. Some studies on the convulsant action of folic acidBr J Pharmacol. (1973)
  95. a b Kehl SJ, McLennan H, Collingridge GL. Effects of folic and kainic acids on synaptic responses of hippocampal neuronesNeuroscience. (1984)
  96. a b Weller M, et al. The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neuronsJ Pharmacol Exp Ther. (1994)
  97. a b Olney JW, et al. Intrastriatal folic acid mimics the distant but not local brain damaging properties of kainic acidNeurosci Lett. (1981)
  98. a b Selhub J, et al. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiencyAm J Clin Nutr. (2009)
  99. ^ Quan FS, et al. Protective effects of folic acid against central nervous system neurotoxicity induced by lead exposure in rat pupsGenet Mol Res. (2015)
  100. ^ Solon O, et al. Associations between cognitive function, blood lead concentration, and nutrition among children in the central Philippines.
  101. ^ Lee MG, Chun OK, Song WO. Determinants of the blood lead level of US women of reproductive ageJ Am Coll Nutr. (2005)
  102. ^ Budni J et al.. Neurotoxicity induced by dexamethasone in the human neuroblastoma SH-SY5Y cell line can be prevented by folic acidNeuroscience. (2011)
  103. ^ Lin Y, et al. Group B vitamins protect murine cerebellar granule cells from glutamate/NMDA toxicityNeuroreport. (2004)
  104. ^ Yu HL, et al. Neuroprotective effects of genistein and folic acid on apoptosis of rat cultured cortical neurons induced by beta-amyloid 31-35Br J Nutr. (2009)
  105. ^ Tagliari B, et al. Hyperhomocysteinemia increases damage on brain slices exposed to in vitro model of oxygen and glucose deprivation: prevention by folic acidInt J Dev Neurosci. (2006)
  106. ^ Bjelland I, et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine StudyArch Gen Psychiatry. (2003)
  107. ^ Kelly CB et al.. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern IrelandJ Psychopharmacol. (2004)
  108. ^ Almeida OP, et al. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later lifeNeurobiol Aging. (2005)
  109. ^ Carney MW, Sheffield BF. Serum folic acid and B12 in 272 psychiatric in-patientsPsychol Med. (1978)
  110. ^ Ramos MI, et al. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortificationAm J Clin Nutr. (2004)
  111. ^ Sachdev PS, et al. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community samplePsychol Med. (2005)
  112. ^ Tolmunen T et al.. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up studyPsychother Psychosom. (2004)
  113. ^ Papakostas GI et al.. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetineInt J Neuropsychopharmacol. (2005)
  114. ^ Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trialJ Affect Disord. (2000)
  115. ^ Passeri M et al.. Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter studyAging (Milano). (1993)
  116. ^ Godfrey PS et al.. Enhancement of recovery from psychiatric illness by methylfolateLancet. (1990)
  117. ^ Taylor MJ, et al. Folate for depressive disordersCochrane Database Syst Rev. (2003)
  118. ^ Loria-Kohen V, et al. A pilot study of folic acid supplementation for improving homocysteine levels, cognitive and depressive status in eating disordersNutr Hosp. (2013)
  119. a b Venkatasubramanian R, Kumar CN, Pandey RS. A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodesJ Affect Disord. (2013)
  120. a b Papakostas GI et al.. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trialsAm J Psychiatry. (2012)
  121. a b Bedson E et al.. Folate Augmentation of Treatment–Evaluation for Depression (FolATED): randomised trial and economic evaluationHealth Technol Assess. (2014)
  122. ^ Sharpley AL, et al. Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trialJ Affect Disord. (2014)
  123. ^ Moens AL, Kass DA. Tetrahydrobiopterin and cardiovascular diseaseArterioscler Thromb Vasc Biol. (2006)
  124. ^ Naseem KM. The role of nitric oxide in cardiovascular diseasesMol Aspects Med. (2005)
  125. ^ Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular diseaseNutr J. (2015)
  126. ^ Zhang M, et al. High‑dose folic acid improves endothelial function by increasing tetrahydrobiopterin and decreasing homocysteine levelsMol Med Rep. (2014)
  127. ^ Moat SJ et al.. High- but not low-dose folic acid improves endothelial function in coronary artery diseaseEur J Clin Invest. (2006)
  128. ^ Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancerCurr Opin Chem Biol. (2009)
  129. ^ Iyer SS et al.. Identification of novel markers for mouse CD4(+) T follicular helper cellsEur J Immunol. (2013)
  130. ^ Jia at el.. A novel splice variant of FR4 predominantly expressed in CD4+CD25+ regulatory T cellsImmunol Invest. (2009)
  131. a b Tian Y et al.. A novel splice variant of folate receptor 4 predominantly expressed in regulatory T cells.BMC Immunol. (2012)
  132. ^ Rogers EJ, Chen S, Chan A. Folate deficiency and plasma homocysteine during increased oxidative stressN Engl J Med. (2007)
  133. ^ Kruman II, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicityJ Neurosci. (2000)
  134. a b Kruman II et al.. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s diseaseJ Neurosci. (2002)
  135. a b Guo X et al.. Protective Effect of Folic Acid on Oxidative DNA Damage: A Randomized, Double-Blind, and Placebo Controlled Clinical TrialMedicine (Baltimore). (2015)
  136. ^ Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2′ -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesisJ Environ Sci Health C Environ Carcinog Ecotoxicol Rev. (2009)
  137. ^ Sutton M, Daly LE, Kirke PN. Survival and disability in a cohort of neural tube defect births in Dublin, IrelandBirth Defects Res A Clin Mol Teratol. (2008)
  138. ^ Hibbard BM, Hibbard ED, Jeffcoate TN. Folic acid and reproductionActa Obstet Gynecol Scand. (1965)
  139. ^ NA. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defectsMMWR Recomm Rep. (1992)
  140. ^ U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statementAnn Intern Med. (2009)
  141. ^ Lewis AS. Rabbit brain purine nucleoside phosphorylase. Physical and chemical properties. Inhibition studies with aminopterin, folic acid and structurally related compoundsArch Biochem Biophys. (1978)
  142. ^ Hollinger JL, et al. In vitro studies of 5, 10-methylenetetrahydrofolate reductase: inhibition by folate derivatives, folate antagonists, and monoamine derivativesJ Neurochem. (1982)
  143. ^ Baggott JE, Vaughn WH, Hudson BB. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5′-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotideBiochem J. (1986)
  144. ^ Allegra CJ, et al. Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamatesProc Natl Acad Sci U S A. (1985)
  145. ^ Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A dietJ Nutr. (1997)
  146. ^ Hollinger JL, et al. In vitro studies of 5, 10-methylenetetrahydrofolate reductase: inhibition by folate derivatives, folate antagonists, and monoamine derivativesJ Neurochem. (1982)
  147. ^ Farias N, et al. The effects of folic acid on global DNA methylation and colonosphere formation in colon cancer cell linesJ Nutr Biochem. (2015)
  148. ^ Kim Yi. Folate and colorectal cancer: an evidence-based critical reviewMol Nutr Food Res. (2007)
  149. ^ Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a reviewJ Nutr. (2002)
  150. ^ Bailey LB, Rampersaud GC, Kauwell GP. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving scienceJ Nutr. (2003)
  151. ^ Choi JH, et al. Contemporary issues surrounding folic Acid fortification initiativesPrev Nutr Food Sci. (2014)
  152. ^ Giovannucci E, et al. Multivitamin use, folate, and colon cancer in women in the Nurses’ Health StudyAnn Intern Med. (1998)
  153. ^ Cole et al.. Folic acid for the prevention of colorectal adenomas: a randomized clinical trialJAMA. (2007)
  154. ^ Hirsch S, et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acidEur J Gastroenterol Hepatol. (2009)
  155. ^ Mattson MP. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivativesPhysiol Rev. (1997)
  156. ^ Triantafyllou NI et al.. Folate and vitamin B12 levels in levodopa-treated Parkinson’s disease patients: their relationship to clinical manifestations, mood and cognitionParkinsonism Relat Disord. (2008)
  157. ^ Triantafyllou NI et al.. The influence of levodopa and the COMT inhibitor on serum vitamin B12 and folate levels in Parkinson’s disease patientsEur Neurol. (2007)
  158. ^ Zoccolella S et al.. Plasma homocysteine levels in Parkinson’s disease: role of antiparkinsonian medicationsParkinsonism Relat Disord. (2005)
  159. ^ Lamberti P, et al. Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson’s disease patientsMov Disord. (2005)
  160. ^ Heikkinen H, et al. Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa doseBr J Clin Pharmacol. (2002)
  161. ^ Naughton CA, et al. Folate absorption in alcoholic pigs: in vitro hydrolysis and transport at the intestinal brush border membraneAm J Clin Nutr. (1989)
  162. ^ Halsted CH, Robles EA, Mezey E. Intestinal malabsorption in folate-deficient alcoholicsGastroenterology. (1973)
  163. ^ Herbet V, Zalusky R, and Davidson CS. Correlation of folate deficiency with alcoholism and associated macrocytosis, anemia, and liver diseaseAnn Intern Med. (1963)
  164. a b Halsted CH, et al. Metabolic interactions of alcohol and folateJ Nutr. (2002)
  165. ^ Halsted C et al.. Decreased Jejunal Uptake of Labeled Folic Acid (3H-PGA) in Alcoholic Patients: Roles of Alcohol and NutritionNEJM. (1971)
  166. ^ McMartin KE, et al. Study of dose-dependence and urinary folate excretion produced by ethanol in humans and ratsAlcohol Clin Exp Res. (1986)
  167. a b Russell RM et al.. Increased urinary excretion and prolonged turnover time of folic acid during ethanol ingestionAm J Clin Nutr. (1983)
  168. ^ Tamura T, Halsted CH. Folate turnover in chronically alcoholic monkeysJ Lab Clin Med. (1983)
  169. a b Lieber CS et al.. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboonHepatology. (1990)
  170. a b Lu SC, et al. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liverAm J Physiol Gastrointest Liver Physiol. (2000)
  171. ^ Mato JM et al.. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trialJ Hepatol. (1999)
  172. a b Amilburu A, et al. Inhibition of intestinal absorption of 5-methyltetrahydrofolate by fluoxetineJ Phys Biochem. (2001)
  173. a b Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief reviewAm J Clin Nutr. (1989)
  174. ^ van der Westhuyzen J, Metz J. Tissue S-adenosylmethionine levels in fruit bats (Rousettus aegyptiacus) with nitrous oxide-induced neuropathyBr J Nutr. (1983)
  175. ^ van der Westhuyzen J, Fernandes-Costa F, Metz J. Cobalamin inactivation by nitrous oxide produces severe neurological impairment in fruit bats : protection by methionine and aggravation by folatesLife Sci. (1982)